to get this rolling again
May and June ASCO 2013 anticipate more mature clinical trial data on ibrutinib .Just be patient.
Sentiment: Strong Buy
It's moving down unopposed today. I bet that's not what you meant, but thanks to low volume and no catalysts, it's being toyed with.